Small dsRNAs induce transcriptional activation in human cells
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Recent studies have shown that small noncoding RNAs, such as microRNAs and siRNAs, regulate gene expression at multiple levels including chromatin architecture, transcription, RNA editing, RNA stability, and translation. Each form of RNA-dependent regulation has been generally found to silence homologous sequences and collectively called RNAi. To further study the regulatory role of small RNAs at the transcriptional level, we designed and synthesized 21-nt dsRNAs targeting selected promoter regions of human genes E-cadherin, p21 WAF1/CIP1 (p21), and VEGF. Surprisingly, transfection of these dsRNAs into human cell lines caused long-lasting and sequence-specific induction of targeted genes. dsRNA mutation studies reveal that the 5′ end of the antisense strand, or “seed” sequence, is critical for activity. Mechanistically, the dsRNA-induced gene activation requires the Argonaute 2 (Ago2) protein and is associated with a loss of lysine-9 methylation on histone 3 at dsRNA-target sites. In conclusion, we have identified several dsRNAs that activate gene expression by targeting noncoding regulatory regions in gene promoters. These findings reveal a more diverse role for small RNA molecules in the regulation of gene expression than previously recognized and identify a potential therapeutic use for dsRNA in targeted gene activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
MethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,729
Self-citationModulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., & Sarnow, P. (2005) · Science · doi:10.1126/science.1113329 · Cited by 2,521
Rational siRNA design for RNA interference
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094
Britten, R. J., & Davidson, E. H. (1969) · Science · doi:10.1126/science.165.3891.349 · Cited by 2,064
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., & Tuschl, T. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.007 · Cited by 2,052
Cited by
Dweep, H., Sticht, C., Pandey, P., & Gretz, N. (2011) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2011.05.002 · Cited by 1,696
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
MicroRNA-373 induces expression of genes with complementary promoter sequences
Place, R. F., Li, L.-C., Pookot, D., Noonan, E. J., & Dahiya, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707594105 · Cited by 1,230
Self-citationDiversifying microRNA sequence and function
Ameres, S. L., & Zamore, P. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3611 · Cited by 1,175
Genetic compensation triggered by mutant mRNA degradation
El-Brolosy, M. A., Kontarakis, Z., Rossi, A., Kuenne, C., Günther, S., Fukuda, N., Kikhi, K., Boezio, G. L. M., Takacs, C. M., Lai, S.-L., et al. (2019) · Nature · doi:10.1038/s41586-019-1064-z · Cited by 1,028
Genetic compensation: A phenomenon in search of mechanisms
El-Brolosy, M. A., & Stainier, D. Y. R. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006780 · Cited by 829
Antisense technology: an overview and prospectus
Crooke, S. T., Baker, B. F., Crooke, R. M., & Liang, X.-H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00162-z · Cited by 775
Non-coding RNAs as regulators of gene expression and epigenetics
Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr097 · Cited by 764
Active DNA Demethylation Mediated by DNA Glycosylases
Zhu, J.-K. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134205 · Cited by 745
hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer
Camps, C., Buffa, F. M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., Harris, A. L., Gleadle, J. M., & Ragoussis, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1755 · Cited by 662
Valinezhad Orang, A., Safaralizadeh, R., & Kazemzadeh-Bavili, M. (2014) · International Journal of Genomics · doi:10.1155/2014/970607 · Cited by 641
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05075-2 · Cited by 623
The Eukaryotic Genome as an RNA Machine
Amaral, P. P., Dinger, M. E., Mercer, T. R., & Mattick, J. S. (2008) · Science · doi:10.1126/science.1155472 · Cited by 619
Adherens Junction: Molecular Architecture and Regulation
Meng, W., & Takeichi, M. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002899 · Cited by 593
Zhang, Y., Wang, Z., & Gemeinhart, R. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.015 · Cited by 535
Targeting long non-coding RNA to therapeutically upregulate gene expression
Wahlestedt, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4018 · Cited by 532
Posttranscriptional Upregulation by MicroRNAs
Vasudevan, S. (2012) · WIREs RNA · doi:10.1002/wrna.121 · Cited by 510
Activating gene expression in mammalian cells with promoter-targeted duplex RNAs
Janowski, B. A., Younger, S. T., Hardy, D. B., Ram, R., Huffman, K. E., & Corey, D. R. (2007) · Nature Chemical Biology · doi:10.1038/nchembio860 · Cited by 505
Karolina, D. S., Armugam, A., Tavintharan, S., Wong, M. T. K., Lim, S. C., Sum, C. F., & Jeyaseelan, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022839 · Cited by 434
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
Lee, H., Deng, J., Kujawski, M., Yang, C., Liu, Y., Herrmann, A., Kortylewski, M., Horne, D., Somlo, G., Forman, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2250 · Cited by 395
RNAi Factors Are Present and Active in Human Cell Nuclei
Gagnon, K. T., Li, L., Chu, Y., Janowski, B. A., & Corey, D. R. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.013 · Cited by 372
Self-citationNuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer
Liu, H., Lei, C., He, Q., Pan, Z., Xiao, D., & Tao, Y. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0765-5 · Cited by 336
Morris, K. V., Santoso, S., Turner, A.-M., Pastori, C., & Hawkins, P. G. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000258 · Cited by 331
Non-coding RNAs, epigenetics and complexity
Costa, F. F. (2008) · Gene · doi:10.1016/j.gene.2007.12.008 · Cited by 317
Baldrich, P., Rutter, B. D., Karimi, H. Z., Podicheti, R., Meyers, B. C., & Innes, R. W. (2019) · The Plant Cell · doi:10.1105/tpc.18.00872 · Cited by 295
MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer
Majid, S., Dar, A. A., Saini, S., Yamamura, S., Hirata, H., Tanaka, Y., Deng, G., & Dahiya, R. (2010) · Cancer · doi:10.1002/cncr.25488 · Cited by 294
Self-citationMehler, M. F., & Mattick, J. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00036.2006 · Cited by 293
Upregulation of Cyclin B1 by miRNA and its implications in cancer
Huang, V., Place, R. F., Portnoy, V., Wang, J., Qi, Z., Jia, Z., Yu, A., Shuman, M., Yu, J., & Li, L.-C. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr934 · Cited by 289
Self-citationRNAi therapeutic and its innovative biotechnological evolution
Weng, Y., Xiao, H., Zhang, J., Liang, X.-J., & Huang, Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.012 · Cited by 286
Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells
Han, J., Kim, D., & Morris, K. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701635104 · Cited by 275
Antisense transcripts are targets for activating small RNAs
Schwartz, J. C., Younger, S. T., Nguyen, N.-B., Hardy, D. B., Monia, B. P., Corey, D. R., & Janowski, B. A. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1444 · Cited by 274
G-quadruplexes regulate Epstein-Barr virus–encoded nuclear antigen 1 mRNA translation
Murat, P., Zhong, J., Lekieffre, L., Cowieson, N. P., Clancy, J. L., Preiss, T., Balasubramanian, S., Khanna, R., & Tellam, J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1479 · Cited by 269
Non-Coding RNAs: Multi-Tasking Molecules in the Cell
Gomes, A., Nolasco, S., & Soares, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816010 · Cited by 261
Al-Mahdawi, S., Pinto, R. M., Ismail, O., Varshney, D., Lymperi, S., Sandi, C., Trabzuni, D., & Pook, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm346 · Cited by 254
Yong, F. L., Law, C. W., & Wang, C. W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-280 · Cited by 176
“Although their main mechanism of action is through mRNA degradation or translational inhibition, they can also induce gene activation [16,17].”
BackgroundMicroRNA miR-324-3p induces promoter-mediated expression of RelA gene
Dharap, A., Pokrzywa, C., Murali, S., Pandi, G., & Vemuganti, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079467 · Cited by 154
“Other examples of small RNA based transcriptional activation also focus on epigenetic modifications such as activation of the VEGF promoter by small ncRNAs via an increase in H3K4me3 levels and a decrease in the repressive mark H3K9me2, thereby resulting in a more accessible chromatin architecture [6].”
BackgroundInfluentialStrickland, E. R., Hook, M. A., Balaraman, S., Huie, J. R., Grau, J. W., & Miranda, R. C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.063 · Cited by 121
Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region
Suzuki, K., Juelich, T., Lim, H., Ishida, T., Watanebe, T., Cooper, D. A., Rao, S., & Kelleher, A. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709651200 · Cited by 108
Resolving subcellular miRNA trafficking and turnover at single-molecule resolution
Pitchiaya, S., Heinicke, L. A., Park, J. I., Cameron, E. L., & Walter, N. G. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.075 · Cited by 98
Direct transcriptional regulation by nuclear microRNAs
Salmanidis, M., Pillman, K., Goodall, G., & Bracken, C. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.03.010 · Cited by 78
“Consistent with cytoplasmic miRNA–mRNA interactions, most miRNA:promoter interactions interrogated by mutagenesis thus far are either exclusively or largely seed-dependent (Li et al., 2006; Place et al., 2008; Younger and Corey, 2011).”
BackgroundInfluentialLiu, D.-Z., Ander, B. P., Tian, Y., Stamova, B., Jickling, G. C., Davis, R. R., & Sharp, F. R. (2012) · Gene · doi:10.1016/j.gene.2011.12.041 · Cited by 59
Control by a hair’s breadth: the role of microRNAs in the skin
Ning, M. S., & Andl, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1117-z · Cited by 48
“These six nucleotides are collectively referred to as the ‘‘seed sequence’’ [14] of the microRNA transcript, and several target prediction algorithms utilize this seed sequence as a major factor in their”
The importance of epigenetics in diagnostics and treatment of major depressive disorder
Czarny, P., Białek, K., Ziółkowska, S., Strycharz, J., Barszczewska, G., & Sliwinski, T. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030167 · Cited by 37
Epigenetic regulation of key vascular genes and growth factors
Turunen, M. P., & Yla-Herttuala, S. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr109 · Cited by 41
RNA-based therapeutics to treat human fungal infections
Bruch, A., Kelani, A. A., & Blango, M. G. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.09.007 · Cited by 39
Metadata
- Authors
- Li, L.-C., Okino, S. T., Zhao, H., Pookot, D., Place, R. F., Urakami, S., Enokida, H., & Dahiya, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-11-14
- Volume
- 103
- Issue
- 46
- Pages
- 17337-17342
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2105444747
- Cited by
- 769
- References
- 36
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.